Revisiting Nitrofurantoin for Vancomycin Resistant Enterococci
Author(s) -
Suneeta Meena,
Sarita Mohapatra,
Seema Sood,
Benu Dhawan,
Bimal Ku Das,
Arti Kapil
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/25140.10140
Subject(s) - nitrofurantoin , enterococcus faecalis , enterococcus , medicine , vancomycin , enterococcus faecium , antimicrobial , microbiology and biotechnology , antibiotics , antibiotic resistance , biology , staphylococcus aureus , bacteria , genetics
Enterococcal infection has emerged as a major therapeutic challenge. Emergence of High Level Aminoglycoside Resistance (HLAR) and Vancomycin-Resistant Enterococcus (VRE) has further limited the drug therapy in enterococcal infections. However, nitrofuratoin being an old drug reported to have less resistance in comparison to the other classes of antimicrobial agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom